Seoul, South Korea

Joo Sung Yang

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Bioneer Corporation, Sungkyunkwan University. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joo Sung Yang. Retrieved from https://idiyas.com/inventor/joo-sung-yang-79019qhs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2012-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Joo Sung Yang: A Pioneer in RNA Therapeutics

Introduction

Joo Sung Yang, based in Seoul, South Korea, is a distinguished inventor known for his significant contributions to the field of RNA therapeutics. With a total of 2 patents to his name, Yang has been at the forefront of innovative solutions for viral infections and cancer treatment. His research efforts focus on developing specific RNA-based therapies that hold the potential for groundbreaking medical advancements.

Latest Patents

Among Yang's latest patents are two notable inventions: a dengue virus-specific siRNA, double helix oligo-RNA structure comprising siRNA, and a composition for suppressing the proliferation of the dengue virus. This invention includes a unique double-stranded oligo-RNA structure designed to efficiently deliver siRNA into cells by incorporating both a hydrophilic compound and a hydrophobic compound. This novel design allows for the formation of nanoparticles in an aqueous solution, enabling effective treatment targeting all dengue virus serotypes. In addition, Yang has developed a DNA vaccine aimed at preventing or treating cervical cancer, which includes genes encoding the E5 protein of the human papillomavirus (HPV) alongside other components.

Career Highlights

Joo Sung Yang’s career includes significant roles in reputable organizations such as Bioneer Corporation and the Sungkyunkwan University Foundation for Corporate Collaboration. Through these positions, he has not only advanced his research but has also contributed to the advancement of the biotech industry in South Korea.

Collaborations

Throughout his career, Yang has collaborated with esteemed professionals in the field, including Woo Seok Kim and Soon Ja Choi. These collaborations have fostered an environment of innovation and shared knowledge, enhancing the overall impact of their collective research endeavors.

Conclusion

Joo Sung Yang exemplifies the spirit of innovation within the biomedical field. His pioneering work in RNA-based therapies for dengue virus and cervical cancer demonstrates a commitment to advancing medical science and improving patient outcomes. As he continues to develop groundbreaking solutions, Yang stands as a testament to the crucial role inventors play in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…